Tag Archives: Bristol-Myers Squibb

Healthcare Sector Highlights: Bristol Myers Squibb (NYSE:BMY), Vermillion (NASDAQ: VRML) – BMY, VRML, JNJ, QCOR, BCR, MNKD, UNIS

Posted on May 16, 2013 by Thomas Vedder

Healthcare sector finished positively on Wednesday’s trading session end and sector hiked +0.15%. If we consider key movers of this sector so Questcor Pharmaceuticals Inc (NASDAQ:QCOR) and BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) were major percentage decliners while key percentage gainers were …

Posted in Healthcare, Latest Headlines | Tagged BCR, BioCryst, BMY, Bristol-Myers Squibb, JNJ, Johnson, MannKind, MNKD, NASDAQ:BCR, NASDAQ:MNKD, NASDAQ:QCOR, NASDAQ:UNIS, NASDAQ:VRML, NYSE:BMY, NYSE:JNJ, QCOR, Questcor, Unilife, UNIS, Vermillion, VRML | Comments Off

Healthcare Sector Roundup: Boston Scientific (NYSE:BSX), Bristol Myers Squibb (NYSE:BMY) – BMY, BSX, JNJ, ALXN, EXAS, BCRX

Posted on April 26, 2013 by Thomas Vedder

Investors responded positively to the healthcare stocks on Thursday. Key movement were observed in Alexion Pharmaceuticals, Inc (NASDAQ:ALXN) and EXACT Sciences Corporation (NASDAQ:EXAS) on percentage gainers side while BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) was major percentage loser.

Boston Scientific Corporation (NYSE:BSX) …

Posted in Healthcare, Latest Headlines | Tagged Alexion Pharmaceuticals, ALXN, BCRX, BioCryst, BMY, Boston Scientific, Bristol-Myers Squibb, BSX, EXACT Sciences, EXAS, JNJ, Johnson, NASDAQ:ALXN, NASDAQ:BCRX, NASDAQ:EXAS, NYSE:BMY, NYSE:BSX, NYSE:JNJ | Comments Off

Sanofi (NYSE:SNY) to Build New Plant in Vietnam to Meet Higher Demand; $75 Million Plan – SNY, BMY, GSK, MRK

Posted on April 1, 2013 by Thomas Vedder

Sanofi SA (ADR) (NYSE:SNY) announced on Friday that it will invest $75 million in a new facility in Vietnam to meet higher demand in the country for pharmaceuticals and consumer healthcare products.

French pharmaceutical company announced on Friday that the …

Posted in Healthcare, Latest Headlines | Tagged BMY, Bristol-Myers Squibb, GlaxoSmithKline, GSK, Merck, MRK, NYSE:BMY, NYSE:GSK, NYSE:MRK, NYSE:SNY, Sanofi SA, SNY | Comments Off

Key Movers in Healthcare Sector: Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE) – GILD, PFE, BMY, RPRX, NBIX, JNJ

Posted on March 29, 2013 by Thomas Vedder

Investors responded positively to the healthcare stocks on Thursday. Key movement were monitored in Repros Therapeutics Inc (NASDAQ:RPRX) and Neurocrine Biosciences, Inc (NASDAQ:NBIX) on percentage gainers side while Johnson & Johnson (NYSE:JNJ) and Gilead Sciences, Inc (NASDAQ:GILD) were most active …

Posted in Healthcare, Latest Headlines | Tagged BMY, Bristol-Myers Squibb, GILD, Gilead Sciences, JNJ, Johnson, NASDAQ:GILD, NASDAQ:NBIX, NASDAQ:RPRX, NBIX, Neurocrine Biosciences, NYSE:BMY, NYSE:JNJ, NYSE:PFE, PFE, Pfizer, Repros Therapeutics, RPRX | Comments Off

Merck & Co. (NYSE:MRK) and Bristol-Myers Squibb Co. (NYSE:BMY) Under FDA Scrutiny

Posted on March 15, 2013 by Geoff Noir

The Food and Drug Administration (FDA) has started a safety assessment of diabetes medicines from Merck & Co. (NYSE:MRK) and Bristol-Myers Squibb Co. (NYSE:BMY) on doubts that they could result in pancreatic diseases, The Wall Street Journal announced late on …

Posted in Latest Headlines | Tagged BMY, Bristol-Myers Squibb, Merck, MRK, NYSE:BMY, NYSE:MRK | Comments Off

Stock Market Movers: Bristol Myers (NYSE:BMY) Inks Deal with Reckitt Benckiser while Barclays (NYSE:BCS) to Shatter Jobs in Strategic Overhaul

Posted on February 12, 2013 by Thomas Vedder

The New York based Bristol Myers Squibb Co (NYSE:BMY) has made a pact under which Reckitt Benckiser Group Plc (LON: RB) will pay it an upfront almost of $438 million for the exclusive rights to vend certain over-the-counter medicines across …

Posted in Latest Headlines | Tagged Barclays, BCS, BMY, Bristol-Myers Squibb, McGraw-Hill, MHP, NYSE:BCS, NYSE:BMY, NYSE:MHP | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.